Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nasal Instillation of Complex Metal Oxide Particles Induces Brain Metal Accumulation and Neurobehavioral Toxicity in Mice.

Environmental science & technology·2026
Same author

What makes a lonely child: environmental, health, and multimodal neuroimaging correlates of prospective loneliness in the ABCD study.

Journal of child psychology and psychiatry, and allied disciplines·2026
Same author

Stage-Related Alterations in Cortical Functional Connectivity Gradients in Non-Dialysis Patients With Chronic Kidney Disease.

AJNR. American journal of neuroradiology·2026
Same author

Sexual health among patients with breast cancer undergoing endocrine therapy: an integrative review.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Towards a general-purpose foundation model for functional MRI analysis.

Nature biomedical engineering·2026
Same author

Topological disruptions of metabolic brain networks in early-stage chronic kidney disease.

BMC medical imaging·2026

Related Experiment Video

Updated: Jun 7, 2026

A Swin Transformer-Based Model for Thyroid Nodule Detection in Ultrasound Images
04:23

A Swin Transformer-Based Model for Thyroid Nodule Detection in Ultrasound Images

Published on: April 21, 2023

2.3K

A token efficient vision framework using patch residual transformer for Alzheimer's disease diagnosis.

Fei Huang1, Pengli Zhu2, Nanguang Chen3

  • 1School of Computer Engineering and Science, Shanghai University, Shanghai, China.

Scientific Reports
|January 9, 2026
PubMed
Summary

A new Patch Residual Transformer (PRT) model improves early Alzheimer's disease (AD) diagnosis and mild cognitive impairment (MCI) conversion prediction using structural MRI. This AI approach enhances focus on critical brain regions, outperforming existing methods.

Keywords:
Alzheimer’s disease diagnosisLinear stitchMCI conversionStructural MRIVision transformer

More Related Videos

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping
07:11

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping

Published on: December 8, 2023

2.3K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K

Related Experiment Videos

Last Updated: Jun 7, 2026

A Swin Transformer-Based Model for Thyroid Nodule Detection in Ultrasound Images
04:23

A Swin Transformer-Based Model for Thyroid Nodule Detection in Ultrasound Images

Published on: April 21, 2023

2.3K
Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping
07:11

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping

Published on: December 8, 2023

2.3K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Neurology

Background:

  • Alzheimer's disease (AD) diagnosis relies on structural magnetic resonance imaging (sMRI), but current AI models like Vision Transformers (ViT) face challenges with data redundancy and feature focus.
  • Early detection of AD and prediction of mild cognitive impairment (MCI) progression are critical for effective intervention.

Purpose of the Study:

  • To introduce a novel, token-efficient framework, the Patch Residual Transformer (PRT), for enhanced sMRI-based AD diagnosis and MCI conversion prediction.
  • To address information redundancy and focus loss issues in ViT models applied to high-dimensional neuroimaging data.

Main Methods:

  • The PRT model partitions sMRI data into patches and utilizes a Patch Residual Block (PRB) with Top-K patch selection and linear stitch patch token fusion (LSPTF).
  • Top-K identifies and ranks critical patches, while LSPTF focuses the model on essential regions, improving efficiency and performance.
  • Validation was performed on the Alzheimer's Disease Neuroimaging Initiative (ADNI) and Open Access Series of Imaging Studies-3 (OASIS-3) datasets.

Main Results:

  • The PRT model significantly outperformed existing slice-, patch-, ROI-, and subject-level methods for both AD diagnosis and MCI conversion prediction.
  • The PRT demonstrated strong generalization capabilities across different datasets.
  • Consistent and robust salience maps were generated, highlighting the model's interpretability.

Conclusions:

  • The PRT framework offers a superior approach for leveraging sMRI data in AD diagnosis and MCI conversion prediction.
  • The proposed PRB, incorporating Top-K and LSPTF, effectively mitigates focus loss and enhances model performance in neuroimaging analysis.
  • PRT shows promise for improving early detection and intervention strategies for Alzheimer's disease.